Article
Prostaglandin Pathway Gene Therapy for Sustained Reduction of Intraocular Pressure
1 Dec 2009
Abstract excerpt
Cyclooxygenase-2 (COX-2) is a rate-limiting enzyme in prostaglandin (PG) biosynthesis. In the eye, loss of COX-2 expression in aqueous humor-secreting cells has been associated with primary open-angle glaucoma (POAG). Reduction of intraocular pressure (IOP) is the main treatment goal in this disease. We used lentiviral vectors to stably express COX-2 and other PG biosynthesis and response transgenes in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
